01 1Corden Pharma Bergamo S.p.A
01 1METRONIDAZOLE USP
01 1Italy
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2012-10-24
Pay. Date : 2012-11-21
DMF Number : 3609
Submission : 1979-09-03
Status : Active
Type : II
20
Corden Pharma Bergamo Spa, based in Italy, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is METRONIDAZOLE USP, with a corresponding US DMF Number 3609.
Remarkably, this DMF maintains an Active status since its submission on September 03, 1979, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of October 24, 2012, and payment made on November 21, 2012, indicating their dedication to facilitating drug approvals, Categorized as Type II
